The NVA-IT nanoparticles did not alter blood parameters including RBCs, Hb, and PCV; thus, the metabolites did not promote anemia, hemorrhage, or hemolysis in the rats and the balance between the rate of formation and death of blood cells was unaffected. The gene discussed is GSTM1; the disease is hemorrhage.